Quark Pharma

A late clinical-stage pharmaceutical company with #siRNA treatments for kidney disease and eye, ear, heart, lung, skin, and nervous system disorders.

[Quark Pharma @QuarkPharma]

There is no specific treatment that is available for these patients, and this is the first time a drug has had... https://t.co/Euq4fpaR9O

[Quark Pharma @QuarkPharma]

There is no specific treatment that is available for these patients, and this is the first time a drug has had... https://t.co/Euq4fpaR9O

[Quark Pharma @QuarkPharma]

Quark takes #RNAi beyond the liver with success in study on
acute #kidney injury after #cardiac #surgery #AKI https://t.co/FFbZwU3Uf3

[Quark Pharma @QuarkPharma]

Thank you, Dr. Peter Quiros @DohenyEye for explaining #NAION symptoms & how to sign up for clinical trial https://t.co/bTr5Kw3RBZ

[Quark Pharma @QuarkPharma]

‘Stroke of the Eye’ symptoms need immediate attention https://t.co/LxEzSJSXd4
#NAION @CBSLA @SereneOnScene

[Quark Pharma @QuarkPharma]

Quark pipeline @PharmExecutive: #SiRNA drugs for DGF #KidneyInjury and eye disease #NAION https://t.co/TyPs0Xkiyu

[Quark Pharma @QuarkPharma]

We're hiring! Open positions @Fremont_CA
- Stability Coordinator/Manager, CMC
- Director, #QualityAssurance
Info: https://t.co/jqBeEvfMmJ

[Quark Pharma @QuarkPharma]

Quark’s Shai Erlich at the #RNA Therapeutics Conference: Why #RNAi drugs could treat conditions that traditional drugs can’t

[Quark Pharma @QuarkPharma]

Quark's Shai Erlich will present at the #RNA Therapeutics meeting in London at 2:10 pm Feb.23 @SMi_Group https://t.co/TGaOo3qh3e

[Quark Pharma @QuarkPharma]

We're hiring! Open positions @Fremont_CA
-Project Manager/Sr. #ProjectManager
-Principal Database #Programmer
Info: https://t.co/jqBeEvfMmJ

[Quark Pharma @QuarkPharma]

We're recruiting people 50-80yr old w sudden #visionloss in the last 14 days for a #NAION treatment study https://t.co/Y0nj3YinCp #EyeActNow

[Quark Pharma @QuarkPharma]

Quark develops #siRNA drugs for unmet medical needs, now in Phase 3 for eye & kidney diseases @biotechnation https://t.co/VLKr3m5Uhr

[Quark Pharma @QuarkPharma]

Check out our #siRNA clinical study on ‘stroke of the eye,’ also known as #NAION https://t.co/Y0nj3YzZ0Z #EyeActNow

[Quark Pharma @QuarkPharma]

Quark CEO Daniel Zurr on our #RNAi drug studies for #AcuteKidneyInjury & #NAION @biotechnation https://t.co/VLKr3m5Uhr

[Optometry Times @OptometryTimes]

.@QuarkPharma launches website designed to step up recruitment for study of drug to treat NAION https://t.co/eSMVfgtFT6 #optometry

[Quark Pharma @QuarkPharma]

Quark Pharmaceuticals Launches https://t.co/Y0nj3YzZ0Z to Promote #NAION Study https://t.co/te1if4ddcR … #ophthalmology

[Rob Wright @RobertFWright]

Companies To Watch: Quark Pharmaceuticals https://t.co/BUytO495C0 @QuarkPharma @WayneKoberstein

[Quark Pharma @QuarkPharma]

Quark Pharmaceuticals Chief Scientist Provides an Overview of the Company's Clinical & Nonclinical Pipelines #SiRNA https://t.co/h6FelxRW76

[Rob Wright @RobertFWright]

Companies To Watch: Quark Pharmaceuticals https://t.co/BUytO495C0 @QuarkPharma @WayneKoberstein

[Quark Pharma @QuarkPharma]

Quark Pharmaceuticals featured in Life Science Leader Magazine: https://t.co/OvaxA4SeCw #RNAi